Marc Gitzinger
12Patents
1h-index
20Co-inventors
50Inventor score
Filing activity: Apr 1, 2010 → Feb 7, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8912329B2 | Composition for treatment of tuberculosis | Chemistry; Metallurgy | 20 | Active |
| US9682079B2 | Composition for treatment of pathogens that are resistant to tetracyclines | Emerging Cross-Sectional Technologies | 1 | Active |
| US11766425B2 | Antibiotic combination therapies | Emerging Cross-Sectional Technologies | 0 | Active |
| US12403133B2 | Rifabutin treatment methods, uses, and compositions | Human Necessities | 0 | Active |
| US12370184B2 | Antibiotic combination therapies | Human Necessities | 0 | Active |
| US11903934B2 | Rifabutin treatment methods, uses, and compositions | Human Necessities | 0 | Active |
| US11344537B2 | Rifabutin treatment methods, uses, and compositions | Human Necessities | 0 | Active |
| US11207305B2 | Antibiotic combination therapies | Emerging Cross-Sectional Technologies | 0 | Active |
| US8653046B2 | Controlling transgene expression across the skin | Chemistry; Metallurgy | 0 | Active |
| US11351158B2 | Rifabutin treatment methods, uses, and compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US12257241B2 | Rifabutin treatment methods, uses, and compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11833139B2 | Rifabutin treatment methods, uses, and compositions | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.